Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study.
Paz-Ares LG, Juan-Vidal O, Mountzios GS, Felip E, Reinmuth N, de Marinis F, Girard N, Patel VM, Takahama T, Owen SP, Reznick DM, Badin FB, Cicin I, Mekan S, Patel R, Zhang E, Karumanchi D, Garassino MC.
Paz-Ares LG, et al. Among authors: zhang e.
J Clin Oncol. 2024 May 31:JCO2400733. doi: 10.1200/JCO.24.00733. Online ahead of print.
J Clin Oncol. 2024.
PMID: 38843511